The 2026 Healthtech Messaging Index

Rank#275of 302

Vellum Health

vellum.health·scored August 23, 2026

32out of 100

12/38

Weak

The signal is faint. Most of this page is about Vellum Health, not the buyer, and AI has little it can repeat. There's a lot of room to move.

WeakAI recommends them? No
Vellum Health homepage

The page we scored

The AI Recommendation Check

When we asked AI who to recommend for Mobile vascular access and IV therapy services for post-acute and home care settings, it named:

Buyer we put in the prompt: Director of Nursing, VP of Clinical Operations, or Chief Medical Officer at a skilled nursing facility, home infusion pharmacy, or health plan. Both the buyer and the category were inferred from Vellum Health’s homepage alone. The model had no web access.

Option Care HealthCoram CVS Specialty Infusion ServicesBioScripAmedisysLHC GroupElara CaringNational Home Infusion Association membersPromptCare

Vellum Health was not on the list.

A buyer who asked AI this question got 8 names and moved on. Vellum Health never came up.

We asked AI who it recommends for "Director of Nursing, VP of Clinical Operations, or Chief Medical Officer at a skilled nursing facility, home infusion pharmacy, or health plan" looking for "Mobile vascular access and IV therapy services for post-acute and home care settings". It named Option Care Health, Coram CVS Specialty Infusion Services, BioScrip, Amedisys, LHC Group. You did not appear. AI can't recommend what it can't clearly understand.

Overall assessment

Vellum Health's biggest strength is solution clarity ... what they do (mobile, on-demand IV services) is immediately understandable and the multi-segment buyer tabs add useful specificity. The biggest gap is proof: there are zero concrete numbers, no named outcomes, no founder authority, and no cost-of-inaction framing anywhere on the page, making every claim feel like marketing assertion rather than evidence ... which will cause both human buyers and AI engines to skip past it.

Signal by category

Narrative Clarity

8 signals

6/16

Trust Signal

4 signals

1/8

AI Signal

6 signals

4/12

Conversion Signal

1 signal

1/2
0

Weakest signal · fix this first

02Rebellion / Movement

No named enemy, challenged status quo, or industry pattern called out anywhere on the page.

The page never names what's broken (e.g., hospital-bound IV care, staffing gaps, unnecessary admissions) nor positions against any status quo ... it's purely feature-forward with no missionary stance.

All 19 signals, scored 0 to 2.

Narrative Clarity

8 signals

6/16
  • 01The 7-Second Test

    Expert vascular access, on demand. Vellum Health offers 24/7 mobile IV enablement, treatment, and clinical education.

    The what is clear enough (mobile IV services), but who it's for and what point of view it takes require scrolling ... the hero doesn't specify the buyer or articulate a distinct POV in 7 seconds.

    1
  • 02Rebellion / Movementweakest

    No named enemy, challenged status quo, or industry pattern called out anywhere on the page.

    The page never names what's broken (e.g., hospital-bound IV care, staffing gaps, unnecessary admissions) nor positions against any status quo ... it's purely feature-forward with no missionary stance.

    0
  • 03Owned Language & Category

    IV enablement" and "AI-native technology" appear, but no defined category name or owned framework.

    The term 'IV enablement' hints at a frame but is never developed into an owned category or named framework that an AI could cite distinctively.

    1
  • 04ICP Clarity

    Payers... Skilled Nursing & Long-Term Acute Care... Home Infusion Pharmacies & Providers... Acute Care

    Four buyer segments are named in tabs, which is good, but they appear mid-page in tabs rather than immediately in the hero, and no company size, role title, or stage is specified.

    1
  • 05Problem Leadership

    Page opens with service listings (IV insertion, PICC lines, blood transfusions) before any articulation of a buyer problem.

    The page leads entirely with solutions and features, never naming a buyer problem or pain in the buyer's own language at any point.

    0
  • 06Solution Clarity

    Vellum Health offers 24/7 mobile IV enablement, treatment, and clinical education.

    A visitor can repeat in one sentence what the company does ... mobile, on-demand IV therapy and training ... making solution clarity the page's strongest narrative element.

    2
  • 07Cost of Inaction

    No mention of cost of delay, risk of hospital readmission, lost revenue, or any consequence of not acting.

    The page never names the price of inaction ... no readmission penalties, no revenue leakage, no patient harm from delayed IV access ... leaving zero urgency on the page.

    0
  • 08Promised Land

    deliver the same quality outcomes at home or in any post-acute setting

    A vague 'after' state is implied (care at home, better outcomes) but no specific, vivid promised land is painted with measurable or emotional specificity.

    1

Trust Signal

4 signals

1/8
  • 09Proof & Evidence

    No percentages, cost savings, readmission reduction rates, or before/after deltas anywhere on the page.

    Every outcome claim is adjective-driven ('better outcomes,' 'high-quality,' 'rigorous') with zero concrete numbers or measurable evidence provided.

    0
  • 10Social Proof

    With Vellum, we can now proactively identify patients needing IV therapy and treat them on-site ... no hospital transfer required." Director of Nursing, Regional Skilled Nursing Facility

    One testimonial exists but the speaker has no name, no facility name, and no quantified result ... logos are present but unaccompanied by any outcome data or named case studies.

    1
  • 11Authority & Credibility

    No founder credentials, original research, awards, frameworks, publications, or demonstrated expertise anywhere on the page.

    Authority is entirely absent ... there is no signal of who built this, what their clinical background is, or any third-party validation beyond logo presence.

    0
  • 12Alternatives Acknowledged

    No mention of competitors, alternatives, in-house staffing models, or 'do nothing' option anywhere on the page.

    The page never acknowledges that buyers could hire vascular access nurses directly, use hospital-based teams, or do nothing ... alternatives are completely ignored.

    0

AI Signal

6 signals

4/12
  • 13Customer Focus

    Care that comes to the patient. Our IV enablement solutions increase patient convenience and organizational value.

    The page mixes company capability language with customer benefit language but tilts toward describing what Vellum does rather than narrating the customer's transformation.

    1
  • 14AI-Parmesan Index

    AI-powered patient intelligence technology easily integrates with your EMR to reveal new care opportunities.

    AI is mentioned twice but with no mechanism, no specifics on how the intelligence works, and no data on what 'new care opportunities' means ... it's AI-Parmesan light, not zero, because there is EMR integration context.

    1
  • 15LLM Quotability

    Move routine, yet costly IV administration out of the hospital and into the home.

    A few declarative sentences exist but they are generic value-prop phrases rather than precise, citation-ready claims an LLM would quote to recommend this company over others.

    1
  • 16Copyright Freshness

    No blog post dates, case study dates, or copyright year visible in the scraped content.

    There are no visible recency signals ... no dated content, no copyright year ... which gives AI engines no freshness signal to weight this content favorably.

    0
  • 17Entity Distinctiveness

    Expert vascular access, on demand" combined with the specific service mix (PICC, midline, blood transfusions, EMR-integrated AI)

    The combination of vascular access specificity and post-acute market focus provides some distinctiveness, but swapping the logo wouldn't fundamentally change the description ... no truly unmistakable positioning frame exists.

    1
  • 18AI Recommendation Check

    AI's picks: Option Care Health, Coram CVS Specialty Infusion Services, BioScrip, Amedisys, LHC Group, Elara Caring. You were not named.

    We asked AI who it recommends for "Director of Nursing, VP of Clinical Operations, or Chief Medical Officer at a skilled nursing facility, home infusion pharmacy, or health plan" looking for "Mobile vascular access and IV therapy services for post-acute and home care settings". It named Option Care Health, Coram CVS Specialty Infusion Services, BioScrip, Amedisys, LHC Group. You did not appear. AI can't recommend what it can't clearly understand.

    0

Conversion Signal

1 signal

1/2
  • 19Path & CTA Clarity

    Schedule a Call" CTA at bottom; "Schedule a procedure" at top; "Learn More" mid-page.

    There are multiple CTAs but no clear primary/secondary hierarchy and no numbered process or path shown ... three competing actions dilute conversion focus without a structured journey.

    1

Your move

Think Vellum Health’s score is wrong? Good. Let’s look at it together.

Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Vellum Health the AI recommendation, and what to write instead.

Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.

← Back to the full Healthtech index